Charles River Buys Singapore's BRASS For Asia Expansion
This article was originally published in PharmAsia News
Executive Summary
Singapore's BRASS, maker of biopharmaceutical and medical products, has been acquired by Charles River Laboratories of the U.S. for an undisclosed amount.